ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $51,000 | +10.9% | 491 | 0.0% | 0.01% | +14.3% |
Q2 2022 | $46,000 | -13.2% | 491 | +9.1% | 0.01% | 0.0% |
Q1 2022 | $53,000 | +1.9% | 450 | +16.9% | 0.01% | 0.0% |
Q4 2021 | $52,000 | -14.8% | 385 | 0.0% | 0.01% | -12.5% |
Q3 2021 | $61,000 | +24.5% | 385 | +3.2% | 0.01% | +14.3% |
Q2 2021 | $49,000 | -2.0% | 373 | -4.8% | 0.01% | 0.0% |
Q1 2021 | $50,000 | -27.5% | 392 | -6.2% | 0.01% | -36.4% |
Q4 2020 | $69,000 | – | 418 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |